Neurocetam

Neurocetam Mechanism of Action

piracetam

Manufacturer:

Micro Labs

Distributor:

Zizawa Healthcare
Full Prescribing Info
Action
Nootropic agent, a new category of drug acting on central nervous system.
Pharmacology: Piracetam improves the cerebral microcirculation by increasing erythrocytes deformability and inhibiting platelet aggregation. It increases regional glucose metabolism in the cerebral cortex, basal ganglia and cerebellum in patients with ischaemic stroke. It also modulates central cholinergic neurotransmission and enhances the efficiency of cortical control over subcortical structures.
Neurocetam Injection: Piracetam, a nootropic agent, directly improves the efficiency of the higher telencephalic functions of the brain involved in the cognitive processes eg, those related to learning, memory, thought and consciousness, both in normal and deficient situations, without being a sedative or psychostimulant.
Mechanism of Action: Piracetam exerts those various activities by different ways of action. It modulates brain neurotransmission and enhances neuronal metabolism by increasing glucose and oxygen uptake.
It improves microcirculation through antispasmodic and haemorrheological properties without being a vasodilator.
Pharmacokinetics: Piracetam is rapidly absorbed when administered orally; peak serum concentration is reached in 45 min. The half-life after oral administration is 4.5 hrs. There is no risk of accumulation. Piracetam crosses the blood-brain barrier and is found in CSF in 2 hrs. Its half-life in CSF is 7.5 hrs. Piracetam is excreted to the extent of about 97% in the urine in the unchanged form.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in